Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for BRD4 (gene)
Most Relevant Literature
- An updated patent review of BRD4 degraders.
- A BRD4-Targeting Photothermal Agent for Controlled Protein Degradation.
- Flipping a switch on BRD4: How to control the do-it-all.
- BRD4 as a therapeutic target for atrial fibrosis and atrial fibrillation.
- Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression.
Most Relevant Clinical Trials
- Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD
- Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherap…
- Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide …
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA180…
- Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment…
